Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• PAD underrecognized, understudied in women
• The value of time must be defended Stephen A. Brietzke, MD
• Consumption of fish with omega-3 lowered CVD risk in young women
• Family tree may predict risk for death from arrhythmia disorders
• FDA approves DES for treatment of CAD patients
• FDA approves nitinol stent for iliac artery disease
• FDA panel recommends approval of obesity drug
• FDA updates safety labeling of statins
• First international guidelines released for ECG diagnosis of rheumatic heart disease
• Grief over losing loved one heightens MI risk
• HF guideline-recommended therapies increased survival benefits
• Meeting greater number of recommended CV health factors lowered risk for death
• Merck discontinues development of oral vernakalant
• Meta-analysis: No benefit of initial PCI vs. medical therapy for stable CAD
• Potassium levels outside recommended range heighten mortality risk after acute MI
• Risk for very late stent thrombosis, late TLR rose steadily up to 5 years after stenting
• Societies release TAVR credentialing recommendations
• Ursodeoxycholic acid improved peripheral blood flow, liver function in chronic HF patients
• VISTA-16 study halted early
• Younger patients more likely to live at least 10 years after heart transplant
• A and B blood groups linked to higher MI risk, not coronary atherosclerosis Calvin W. Roberts, MD; William L. Roberts, MHA, CPA; Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA; Brandon A. Roberts, MSc, MD
• Automated monitoring system allowed earlier detection of ICD problems
• BMI influenced quality of life among AF patients
• Dietary counseling significantly lowered lipoprotein levels in boys only
• Moderate to vigorous physical activity improved cardiometabolic risk factors in children regardless of time spent sedentary
• New-onset AF common in patients undergoing TAVI
• Obese NFL players face higher CVD mortality
• Paclitaxel-coated balloon angioplasty superior to balloon angioplasty alone for DES restenosis
• Physicians, patients disagree about shared access to medical records
• Statin use may decrease risk for Parkinson’s disease
• Trans-fatty acid levels decreased in whites after FDA regulation
• Younger women more likely than men to experience MI without chest pain
• ACRIN: Coronary CTA accurately predicted 30-day risk
• Anemia triples risk for death after stroke
• Apixaban more effective than aspirin in reducing stroke recurrence
• Aspirin use for secondary prevention low in stroke patients
• Certain conotruncal defects require chromosome deletion syndrome screening
• Half of stroke survivors in US have poorly controlled hypertension
• IV stem cell therapy safe for stroke patients
• Moderate exercise lowered genetic predisposition to obesity
• Physicians with healthy habits likely to urge lifestyle changes to patients
• REGARDS: Dietary patterns based on demographics identified in US adults
• Self-sustaining cardiac surgery program established in Ghana
• Sleep deprivation may increase caloric intake
• Stem cell trial failed to meet primary endpoint, but data advance the field
• Stroke, death risk higher in patients with new-onset AF hospitalized for severe sepsis
• TAVR with CoreValve device safe at 6 months
• Two studies show promising, durable results for renal denervation
• Vitamin D may protect against stroke, cognitive impairment
• Wii-based movement therapy improved CV fitness after stroke
• Dronedarone: A review of the latest data and label changes
• ALSPAC
• HAART
• NOMAS
• PEPCAD-DES
• PRIMO
• PROTECT AF
• REGARDS
• TARGET